Clinical trial Recruiting at 1 site Interventional Ages 18 to 65

Effects of different amounts of mindfulness meditation on well-being

Official title: Examining Dose-Response Effects of Mindfulness Meditation Interventions on Wellbeing: A Randomized Controlled Trial

Run by University of Melbourne · NCT06378450 · Data updated 2026-11-12

This study is testing if different amounts of mindfulness meditation can improve well-being in healthy adults who haven't meditated much before.

More Depression trials

Quick facts

Study typeInterventional
Ages18 Years to 65 Years
SexAll
Enrollment860 (estimated)
SponsorUniversity of Melbourne
Academic / other
Locations1 site (Carlton, Victoria)
StatusRecruiting
StartedMay 1, 2024
Main results expectedApril 30, 2025
Study endsJune 30, 2025
Registry record updatedMarch 30, 2025
Trial IDNCT06378450 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are healthy adults residing in Australia with minimal prior experience in meditation.

Probably not a fit

Patients with severe anxiety or depression symptoms may not benefit unless they are receiving ongoing treatment for their conditions.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This randomized controlled trial aims to investigate the dose-response effects of mindfulness meditation on well-being in healthy adults with little to no prior meditation experience. Participants will be assigned to one of four groups receiving varying durations of daily meditation practice—10, 20, or 30 minutes, or a minimal dose of 3-4 minutes—over a 28-day period. The study will assess changes in well-being through self-reported measures at multiple time points, while also monitoring participant engagement and adherence to the meditation regimen. The goal is to determine whether longer meditation sessions lead to greater improvements in psychological well-being.

Why it matters

Potential benefit: If successful, this study could provide insights into optimal meditation practices that enhance well-being and mental health.

How similar studies have gone: Previous studies have shown positive effects of mindfulness meditation on well-being, but this specific dose-response approach is relatively novel.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Reside in Australia, with no plans to relocate or travel overseas during the intervention period;
* Sufficient comprehension of the English language to complete measures;
* Register for an account and agree to the Terms and Conditions of Unforgettable.Me;
* If suffering anxious or depressive symptoms of moderate severity (defined by \> 19 on the Patient-Reported Outcomes Measurement Information System \[PROMIS\] Level 2 Anxiety or \> 22 on the PROMIS Level 2 Depression), must agree to continue recommended routine medical treatment for eligible underlying mental and/or physical health conditions or the duration of the study and to seek additional treatment if indicated by deterioration of symptoms;
* No or minimal experience with meditation, defined as less than 25 hours over the past 6 months; never attended a multi-day mindfulness course (e.g., Mindfulness-Based Stress Reduction, Vipassana). If 50% of our target sample size has not bee recruited within the first three months of active recruitment, the inclusion criteria will be broadened to include participants with up to 100 hours in the past 6 months.

Exclusion Criteria:

* Self-reported current or lifetime serious mental illness (e.g., neurodevelopmental, schizophrenia spectrum, bipolar, obsessive-compulsive, trauma-related, dissociative or personality disorder);
* Anxious and depressive symptoms in the severe range (defined by \>27 on the PROMIS Level 2 Anxiety or \> 32 on the PROMIS Level 2 Depression);
* Psychological distress symptoms in the severe range (Kessler Psychological Distress Scale \[K10\] \>= 30);
* Threshold scores on pre-screening and follow-up measures exceeded for Mania, Suicidal Ideation, Psychosis, Repetitive Thoughts \& Behaviors, Dissociation
* Moderate alcohol, tobacco, or drug use;
* Self-reported diagnosis of neurological condition (e.g., traumatic brain injury, amnesia, epilepsy, stroke, etc.);
* Self-reported presence of any serious medical condition (e.g., cancer, thyroid disorder, multiple sclerosis, etc.);
* Recent bereavement or major loss;
* History of unexplored, untreated traumatic experiences or adverse childhood events.

Where it's running

  • Contemplative Studies Centre, The University of Melbourne
    Carlton, Victoria, Australia
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.